A cell-free biosynthesis platform for modular construction of protein glycosylation pathways (Q91496476)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

title

A cell-free biosynthesis platform for modular construction of protein glycosylation pathways (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Katherine E Duncker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Ashvita Ramesh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Ariel H Thames

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Aravind Natarajan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Jessica C Stark

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Liang Lin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Milan Mrksich

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Matthew P. DeLisa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Michael C Jewett

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

author name string

Allen Yang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

publication date

27 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

published in

Nature Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

page(s)

5404

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

Intracellular functions of N-linked glycans

22 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Challenges in therapeutic glycoprotein production

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Enhancement of therapeutic protein in vivo activities through glycoengineering

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Sialic acids in human health and disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing alpha-gal epitopes

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

A common glycan structure on immunoglobulin G for enhancement of effector functions

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Optimization of humanized IgGs in glycoengineered Pichia pastoris.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Engineered CHO cells for production of diverse, homogeneous glycoproteins.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Chemical and chemoenzymatic synthesis of glycoproteins for deciphering functions

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

An engineered eukaryotic protein glycosylation pathway in Escherichia coli.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

The N-linking glycosylation system from Actinobacillus pleuropneumoniae is required for adhesion and has potential use in glycoengineering.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Molecular analysis of an alternative N-glycosylation machinery by functional transfer from Actinobacillus pleuropneumoniae to Escherichia coli.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Single-pot glycoprotein biosynthesis using a cell-free transcription-translation system enriched with glycosylation machinery.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

A prokaryote-based cell-free translation system that efficiently synthesizes glycoproteins.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Design of glycosylation sites by rapid synthesis and analysis of glycosyltransferases

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

A cell-free framework for rapid biosynthetic pathway prototyping and enzyme discovery.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Cell-Free Mixing of Escherichia coli Crude Extracts to Prototype and Rationally Engineer High-Titer Mevalonate Synthesis.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Cell-free metabolic engineering: biomanufacturing beyond the cell

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Cell-free protein synthesis from genomically recoded bacteria enables multisite incorporation of noncanonical amino acids.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Molecular basis of lipid-linked oligosaccharide recognition and processing by bacterial oligosaccharyltransferase.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

A biosynthetic route for polysialylating proteins in Escherichia coli.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Cytoplasmic N-glycosyltransferase of Actinobacillus pleuropneumoniae is an inverting enzyme and recognizes the NX(S/T) consensus sequence

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

A two-step enzymatic glycosylation of polypeptides with complex N-glycans

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

A novel enzymatic method for synthesis of glycopeptides carrying natural eukaryotic N-glycans.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Increasing the sialylation of therapeutic glycoproteins: the potential of the sialic acid biosynthetic pathway

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Discovery of glycosyltransferases using carbohydrate arrays and mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Assessment of the two Helicobacter pylori alpha-1,3-fucosyltransferase ortholog genes for the large-scale synthesis of LewisX human milk oligosaccharides by metabolically engineered Escherichia coli.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Metabolic engineering of Escherichia coli for the production of 2'-fucosyllactose and 3-fucosyllactose through modular pathway enhancement

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Donor substrate promiscuity of bacterial β1-3-N-acetylglucosaminyltransferases and acceptor substrate flexibility of β1-4-galactosyltransferases

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

A new fermentation process allows large-scale production of human milk oligosaccharides by metabolically engineered bacteria

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Predicted functions and linkage specificities of the products of the Streptococcus pneumoniae capsular biosynthetic loci

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Site-specific enzymatic polysialylation of therapeutic proteins using bacterial enzymes

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Different Sialoside Epitopes on Collagen Film Surfaces Direct Mesenchymal Stem Cell Fate

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Microbial recognition of human cell surface glycoconjugates

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Siglecs as targets for therapy in immune-cell-mediated disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

In vivo targeting of B-cell lymphoma with glycan ligands of CD22.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

A rationally engineered yeast pyruvyltransferase Pvg1p introduces sialylation-like properties in neo-human-type complex oligosaccharide

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

The Next Step in Biomimetic Material Design: Poly-LacNAc-Mediated Reversible Exposure of Extra Cellular Matrix Components

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Tailored Multivalent Neo-Glycoproteins: Synthesis, Evaluation, and Application of a Library of Galectin-3-Binding Glycan Ligands.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

A role for fucose alpha(1-2) galactose carbohydrates in neuronal growth

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Human milk contains novel glycans that are potential decoy receptors for neonatal rotaviruses

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

A multifunctional Pasteurella multocida sialyltransferase: a powerful tool for the synthesis of sialoside libraries

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Glycomimicry: display of fucosylation on the lipo-oligosaccharide of recombinant Escherichia coli K12.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Glycomimicry: display of the GM3 sugar epitope on Escherichia coli and Salmonella enterica sv Typhimurium

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Exploiting bacterial glycosylation machineries for the synthesis of a Lewis antigen-containing glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Portable, On-Demand Biomolecular Manufacturing.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

On-demand manufacturing of clinical-quality biopharmaceuticals

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Modulating the innate immune response by combinatorial engineering of endotoxin

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Endotoxin-Free E. coli-Based Cell-Free Protein Synthesis: Pre-Expression Endotoxin Removal Approaches for on-Demand Cancer Therapeutic Production

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Novel N-glycosylation in eukaryotes: laminin contains the linkage unit beta-glucosylasparagine

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

N-Glycosyltransferase from Aggregatibacter aphrophilus synthesizes glycopeptides with relaxed nucleotide-activated sugar donor selectivity

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Enzymatic assembly of DNA molecules up to several hundred kilobases

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Engineered oligosaccharyltransferases with greatly relaxed acceptor-site specificity

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Translation rate is controlled by coupled trade-offs between site accessibility, selective RNA unfolding and sliding at upstream standby sites.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Immunization with Outer Membrane Vesicles Displaying Designer Glycotopes Yields Class-Switched, Glycan-Specific Antibodies

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Efficient production of a bioactive, multiple disulfide-bonded protein using modified extracts of Escherichia coli

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

One-step cloning and chromosomal integration of DNA.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-12024-9

7 January 2021

10.1038/S41467-019-12024-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31776339%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

1 reference